EU Outlines New Rules On Releasing Drug Trial Data

Law360, Washington (June 24, 2013, 3:10 PM EDT) -- The European Medicines Agency on Monday released details of its plan to make drug sponsors' clinical trial data public, claiming the new policy will enhance public health and drug development while protecting innovation.

Starting in January 2014, EMA plans to release clinical trial data on newly approved pharmaceutical drugs, which it claims will foster transparency and promote faster innovation. The agency noted that third-party stakeholders have been clamoring for additional clinical trial data disclosure as well as a more transparent regulatory decision-making process.

“Allowing external parties...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.